ADIR Association   Report issue

Academic/Hospital Phase 1 Phase 2
Founded: Rouen France (1976)

Organization Overview

First Clinical Trial
2016
NCT02805439
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

ADIR Association | ADIR Association, Bois-Guillaume, France

Active Ingredients

Drugs in Phase 2 Trials (4)

paclitaxel (taxol) (1 trial)

s 44819 (1 trial)

s47445 (1 trial)

s81694 (1 trial)

Drugs in Phase 1 Trials (2)

mrg-110 (1 trial)

s64315 (1 trial)

Drugs in Other Trials (1)

albuterol (proventil) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Breast Neoplasms (Phase 2)

Cardiovascular Diseases (Phase 1)

Depression (Phase 2)

Depressive Disorder (Phase 2)

Depressive Disorder, Major (Phase 2)

Leukemia (Phase 1)

Leukemia, Myeloid (Phase 1)

Leukemia, Myeloid, Acute (Phase 1)

Myelodysplastic Syndromes (Phase 1)

Preleukemia (Phase 1)

Syndrome (Phase 1)

Triple Negative Breast Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 6
  • # of Trial APIs: 7